CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview with a focus on delivery and scientific leadership of RNAi therapeutics at the Bank of America 2008 Specialty Pharmaceuticals Conference on Friday, August 8, 2008, at 8:00 a.m. ET at the Southampton Inn in Southampton, New York.
